SecBot SecBot
8-K ·Filed Apr 22, 2026
MD

MDAIW

Spectral AI, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed6mo ago SEC0001213900-26-046405
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for potential executive turnover or governance instability, as the CEO appointment follows a contested election. The guaranteed bonus and immediate RSU vesting signal a focus on retention during a period of transition.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
MDAIW ▲ +12.00% at T+60d
NEUTRAL call +12.00% · α vs SPY +7.22% · entry $0.5000 → $0.5600
Entry = T+0 close
Apr 22, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.39%
$0.5000
settled 6mo ago
T+5d
+35.82%
call +35.82% · α +35.77%
$0.6791
settled 6mo ago
T+20d
0.00%
call 0.00% · α -3.17%
$0.5000
settled 5mo ago
T+60d
+12.00%
call +12.00% · α +7.22%
$0.5600
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Spectral AI announced the formal employment agreement with Vincent S. Capone as Chief Executive Officer, including compensation details. This follows a contested shareholder vote on director elections disclosed in a prior filing.

Key Facts

  • Vincent S. Capone was formally appointed as CEO via an employment agreement dated April 17, 2026.
  • Capone's compensation includes a $500,000 annual base salary, a guaranteed minimum bonus of $250,000, and a grant of 200,000 restricted stock units (50% vested immediately, 50% in 2027).
  • The announcement comes just 6 days after a contested proxy vote (DEFA14A) to elect the board, indicating ongoing leadership and governance changes.

Financial Impact

The RSU grant of 200,000 shares represents a significant non-cash compensation expense. Based on the $24M market cap, this is a material dilution event.

dilutioncompensation

Risk Factors

  • High executive compensation could strain finances for a company with a $24M market cap.
  • Contested election and immediate CEO appointment suggest potential internal board conflict or shareholder activism.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-046405
Document: ea0287202-8k_spectral.htm0001213900-26-046405
Document: 0001213900-26-046405-index-headers.html0001213900-26-046405
Document: 0001213900-26-046405-index.html0001213900-26-046405
Document: 0001213900-26-046405.txt0001213900-26-046405
3 reports for MDAIW
Performance horizon
Filters
Rows
Reports for MDAIW — sortable, filterable
TypeNow
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$0.5000 $0.6000▲ +20.00%▲ +21.57%—
Apr 22, 2026
26w ago
8-K
NEUTRAL ★ 4/10
$0.5000 $0.5000· 0.00%▼ −3.17%—
Apr 8, 2026
28w ago
8-K
NEUTRAL ★ 3/10
$0.5000 $0.5000· 0.00%▼ −7.57%—
Showing 3 of 3

US Market Status

Market Open — Closes in 2h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026